BAYS F BARRY 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Apr 13, 2023
Insider Transaction Report
Form 4
BAYS F BARRY
Director
Transactions
- Sale
Common Stock
2023-04-11$26.28/sh−44,764$1,176,286→ 1,160,021 total - Sale
Common Stock
2023-04-12$26.12/sh−36,370$950,104→ 1,118,625 total - Sale
Common Stock
2023-04-11$27.28/sh−5,026$137,108→ 1,154,995 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0100 to $26.9700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $27.1500 to $27.5700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.8400 to $26.5050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.